UDC 338

Fedin E.Yu.¹ (Moscow, Russian Federation) – fedine876@gmail.com; Anisimov A.Yu.¹ (Moscow, Russian Federation) – anisimov_au@mail.ru

¹Synergy University

Abstract. Amid macroeconomic and political upheavals, global supply chains are demonstrating high instability caused by a combination of internal and external factors. This situation is driven by the deep interdependence of global production and transportation systems, narrow specialization in the supply of key components, and strict regulatory requirements for medical devices. Sanction restrictions have clearly demonstrated the vulnerability of global medical and pharmaceutical equipment supply chains. Therefore, the objective of this study is to substantiate the key vectors for optimizing the supply chain logistics of technological equipment as a factor in increasing the resilience and competitiveness of pharmaceutical companies in the face of increasing exogenous shocks. The objectives include assessing the dynamics of the global pharmaceutical equipment market and the degree of supply concentration, as well as identifying factors that influence the resilience of pharmaceutical equipment supply chains.The study identified trends in the global pharmaceutical equipment market, noting its high concentration and dependence on leading Western manufacturers. Supply chain management for pharmaceutical equipment at the intra-organizational, inter-organizational, and exogenous levels was identified as a key challenge for the development of the pharmaceutical industry. It is substantiated that, under current conditions, systemic optimization of logistics processes is a critical factor in ensuring the continuity of the production process, technological resilience, and competitiveness of domestic pharmaceutical companies, capable of reducing the disintegration of information and physical flows of pharmaceutical equipment supply.

Keywords: supply chain management; pharmaceutical equipment; sanctions; supply chain resilience factors.

1. Bazueva, E. V., Oborina, E. D., & Kovaleva, T. Y. (2016). Substantiation of prerequisites for the formation and development of highly efficient clusters in the regional economy: A review of domestic and foreign experience. Perm University Herald. Economy, 2(19), 93–108. (In Russian). https://doi.org/10.17072/1994-6690-2016-2-93-108
2. Kerimbekova, Z. (2025). GDP (good distribution practice) as a logistics quality standard in pharmaceuticals: Application and control. Vestnik Nauki, 4-6, 1599–1612. (In Russian).
3. Zongxiang, H. (2008). Research on supply chain management innovation in the mechanical fundamentals industry. In Proceedings of the 2008 International Conference on Information Management, Innovation Management and Industrial Engineering (Vol. 2, pp. 454–457). IEEE. https://doi.org/10.1109/ICIII.2008.113
4. Punniyamoorthy, M., Thamaraiselvan, N., & Manikandan, L. (2013). Assessment of supply chain risk: Scale development and validation. Benchmarking: An International Journal, 20(1), 79–105. https://doi.org/10.1108/14635771311299506
5. Kumar, S., Luthra, S., & Haleem, A. (2015). Benchmarking supply chains by analyzing technology transfer critical barriers using AHP approach. Benchmarking: An International Journal, 22(4), 538–558. https://doi.org/10.1108/BIJ-05-2014-0040
6. Ward, M., Halliday, S., Uflewska, O., & Wong, T. C. (2017). Three dimensions of maturity required to achieve future state, technology-enabled manufacturing supply chains. Proceedings of the Institution of Mechanical Engineers, Part B: Journal of Engineering Manufacture, 232(4), 605–620. https://doi.org/10.1177/0954405417710045
7. Cigolini, R., Gosling, J., Iyer, A., & Senicheva, O. (2022). Supply chain management in construction and engineer-to-order industries. Production Planning & Control, 33(9–10), 803–810. https://doi.org/10.1080/09537287.2020.1837981
8. Shuvalov, S. S. (2022). Development of contractual forms of organization of production of critically important products under sanctions. ETAP: Economic Theory, Analysis, Practice, 3, 49–63. (In Russian). https://doi.org/10.24412/2071-6435-2022-3-49-63
9. Mamedov, N. G. O. (2022). Modeling of an optimal supply chain management system in transport systems. Vestnik of Dagestan State Technical University. Technical Sciences, 49(3), 82–90. (In Russian). https://doi.org/10.21822/2073-6185-2022-49-3-82-90
10. Nekrasov, A. G., & Sinitsyna, A. S. (2021). Digital evolution of supply chain life cycle processes. Greater Eurasia: Development, Security, Cooperation, 4-1, 483–492. (In Russian).
11. Kononov, A. N. (2024). Crisis of pharmaceutical distribution: Factors of deformation of contracting conditions in the товаропроводящей logistics chain of the market. Journal of Monetary Economics and Management, 12, 8–14. (In Russian). https://doi.org/10.26118/2782-4586.2024.90.80.149
12. Ahmad, F., Alnowibet, K. A., Alrasheedi, A. F., & Adhami, A. Y. (2022). A multi-objective model for optimizing the socio-economic performance of a pharmaceutical supply chain. Socio-Economic Planning Sciences, 79, 101126. https://doi.org/10.1016/j.seps.2021.101126
13. Adeniran, I. A., Efunniyi, C. P., Osundare, O. S., & Abhulimen, A. O. (2024). Optimizing logistics and supply chain management through advanced analytics: Insights from industries. Engineering Science & Technology Journal, 5(8). https://doi.org/10.56781/ijsret.2024.4.1.0020
14. Cognitive Market Research. (2025). Pharmaceutical machinery market report 2025. https://www.cognitivemarketresearch.com/pharmaceutical-machinery-market-report
15. Kovalenko, A. V., Khalimova, A. A., Safronova, Z. S., & Polyakova, Y. Y. (2022). Withdrawal of foreign capital from the pharmaceutical industry in Russia. Medico-Pharmaceutical Journal “Pulse”, 24(8), 36–41. (In Russian).
16. Sanket, J. S., & Ankitkumar, N. P. (2024). Review on pharmaceutical supply chain resilience: Strategies for managing disruptions and ensuring continuity. World Journal of Current Medical and Pharmaceutical Research, 8–14. https://doi.org/10.37022/wjcmpr.v6i3.341
17. Giri, V., Madaan, J., Varma, N., & Charan, P. (2024). Flexible decision framework for resilient healthcare supply chain systems focusing pharmaceutical industry. Global Journal of Flexible Systems Management, 25(3), 487–512. https://doi.org/10.1007/s40171-024-00392-1
18. Yang, W., & Zelbst, P. (2024). Enhancing crisis resilience in healthcare supply chains: A strategic and tactical framework for crisis management readiness assessment (Report No. IHS/CR-2024-1012). Sam Houston State University Institute for Homeland Security.
19. Mogale, D. G., Xian, D., & Sanchez Rodrigues, V. (2025). Managing logistics risks in pharmaceutical supply chain: A 4PL perspective. Production Planning & Control, 36(10), 1414–1429. https://doi.org/10.1080/09537287.2024.2363938
20. Kanike, U. K. (2023). Factors disrupting supply chain management in manufacturing industries. Journal of Supply Chain Management Science, 4(1–2), 1–24. https://doi.org/10.18757/jscms.2023.6986
21. Erasova, E. A. (2015). Import substitution as a factor in ensuring pharmaceutical security in modern Russia. Proceedings of the St. Petersburg Branch of the Russian Customs Academy named after V. B. Bobkov, 3(55), 14–26. (In Russian).
22. Hansen, Z. N. L., Andreu, C. M., Khan, O., Haug, A., Hvam, L., & Hansen, N. E. (2023). Identification of key drivers for improving inventory management in pharmaceutical supply chains. Production Engineering, 17(5), 763–772. https://doi.org/10.1007/s11740-023-01199-2

For citation: Fedin, E. Yu., & Anisimov, A. Yu. (2026). Optimization of pharmaceutical and medical equipment supply chains as a factor in the development of the pharmaceutical industry under sanctions. CITISE, 2, 791–803. (In Russian).